However, for patients who prefer or require oral administration, the pill offers substantial, clinically meaningful results
Semasize Injection Cartridge contains Semaglutide , a GLP-1 receptor agonist used to help manage blood sugar levels in adults with type 2 diabetes and support weight management Product Overview Semasize Injection Cartridge contains Semaglutide, a medicine that mimics the action of GLP-1 (glucagon-like peptide-1), a naturally occurring hormone involved in blood sugar regulation and appetite control
Semaglutide is the better choice for patients with cardiovascular disease
However, semaglutide products are already approved for specific uses, while retatrutide remains investigational
You should not take the following drugs with semaglutide (Wegovy): Other GLP-1 receptor agonists such as liraglutide (Saxenda, Victoza), dulaglutide (Trulicity), lixisenatide (Soliqua), and exenatide (Bydureon, Byetta)
Retatrutides withdrawal data hasnt been published yet